Ernie Talarico
Gründer bei Talarico Ataxia Foundation
Profil
Mr. Ernest J.
Talarico, III, is a Senior Managing Director at Mesirow Financial Investment Management, Inc. Mr. Talarico is also a relationship manager and investment committee member in Mesirow Financial’s Retirement Planning and Advisory group.
He helps qualified retirement plan sponsors effectively establish and maintain their fiduciary process.
Mr. Talarico also works with high net worth individuals, business owners and not-for profit entities to create comprehensive wealth management strategies.
He joined Mesirow Financial in 1998.
Mr. Talarico is also a member of the firm’s select advisory board, which is responsible for performing due diligence on external money managers.
He serves on the board of directors for NewLink Genetics, a biotech company located in Ames, Iowa.
He earned a BA from the University of Iowa and is an Accredited Investment Fiduciary (AIF).
Aktive Positionen von Ernie Talarico
| Unternehmen | Position | Beginn |
|---|---|---|
Mesirow Financial Holdings, Inc.
 Mesirow Financial Holdings, Inc. Financial ConglomeratesFinance Mesirow Financial Holdings, Inc. provides financial services. Its services include investment, real estate, investment banking, consulting and insurance services. The company was founded in 1937 and is headquartered in Chicago, IL. | Corporate Officer/Principal | 01.01.2003 |
| Talarico Ataxia Foundation | Gründer | 23.12.2010 |
Mesirow Financial Investment Management, Inc.
 Mesirow Financial Investment Management, Inc. Investment ManagersFinance Mesirow Financial Investment Management, Inc. (MFIM) is a SEC-registered investment advisor headquartered in Chicago, Illinois. The firm was established in 1986 and their sole shareholder is Mesirow Financial Services, Inc., which is wholly-owned by Mesirow Financial Holdings, Inc., a Chicago-based financial services firm that was founded in 1937. MFIM provides advisory services to individuals, corporations or other businesses, pension and profit-sharing plans, non-qualified plans, state or municipal government entities, and charitable organizations. | Mitglied des Investmentausschusses | 01.10.1998 |
Benevolent Enabler, Inc.
 Benevolent Enabler, Inc. Packaged SoftwareTechnology Services Benevolent Enabler, Inc. develops application software. The private company is based in New Orleans, LA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ernie Talarico
| Unternehmen | Position | Ende |
|---|---|---|
| LUMOS PHARMA, INC. | Direktor/Vorstandsmitglied | 18.03.2020 |
Ausbildung von Ernie Talarico
| University of Iowa | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Mesirow Financial Investment Management, Inc.
Mesirow Financial Investment Management, Inc. Investment ManagersFinance Mesirow Financial Investment Management, Inc. (MFIM) is a SEC-registered investment advisor headquartered in Chicago, Illinois. The firm was established in 1986 and their sole shareholder is Mesirow Financial Services, Inc., which is wholly-owned by Mesirow Financial Holdings, Inc., a Chicago-based financial services firm that was founded in 1937. MFIM provides advisory services to individuals, corporations or other businesses, pension and profit-sharing plans, non-qualified plans, state or municipal government entities, and charitable organizations. | Finance |
Mesirow Financial Holdings, Inc.
Mesirow Financial Holdings, Inc. Financial ConglomeratesFinance Mesirow Financial Holdings, Inc. provides financial services. Its services include investment, real estate, investment banking, consulting and insurance services. The company was founded in 1937 and is headquartered in Chicago, IL. | Finance |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
| Talarico Ataxia Foundation | |
Benevolent Enabler, Inc.
Benevolent Enabler, Inc. Packaged SoftwareTechnology Services Benevolent Enabler, Inc. develops application software. The private company is based in New Orleans, LA. | Technology Services |
